1257553-85-7 Usage
General Description
2-propoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine is a chemical compound that belongs to the class of pyridine derivatives. It is a boronic ester containing a pyridine ring and a propoxy group. 2-propoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine has potential applications in organic synthesis and materials science, particularly in the field of organic optoelectronics and pharmaceuticals. The presence of boron in the molecule lends it unique reactivity and selectivity in certain chemical reactions, making it a valuable building block for the synthesis of complex organic molecules. Furthermore, the presence of the pyridine ring enhances the compound's potential as a ligand in transition metal-catalyzed reactions and in the coordination chemistry of boron compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1257553-85-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,7,5,5 and 3 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1257553-85:
(9*1)+(8*2)+(7*5)+(6*7)+(5*5)+(4*5)+(3*3)+(2*8)+(1*5)=177
177 % 10 = 7
So 1257553-85-7 is a valid CAS Registry Number.
1257553-85-7Relevant articles and documents
ALKYNE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS
-
Page/Page column 76; 77; 86; 87; 110, (2016/05/02)
Provided are compounds of formula (Ia) and pharmaceutically acceptable salts thereof, wherein A, B, R 1, R 2, m and n are as defined herein, which are active as inhibitors of S-Nitrosoglutathione reductase (GSNOR). These compounds prevent, inhibit, or suppress the action of GSNOR and are therefore useful in the treatment of GSNOR mediated diseases, disorders, syndromes or conditions such as, e.g., pulmonary hypertension, acute respiratory distress syndrome (ARDS), asthma, bronchospasm, cough, pneumonia, pulmonary fibrosis, interstitial lung diseases, cystic fibrosis and chronic obstructive pulmonary disease (COPD).
